Furthermore, serum levels of SOX9 and lncRNA-ANRIL (Antisense Non-coding RNA in the INK4 Locus) were higher in patients with glioma than in healthy people and were strongly associated with unfavorable prognosis [57]. This evidence concerns the gene SOX9 and central nervous system cancer.